Novo Nordisk announced the launch of NovoFine Plus, their thinnest and shortest pen needles currently available. These needles are compatible with all available insulin and some GLP-1 receptor agonist pens.
NovoFine Plus needles, measuring 32G x 4mm, utilize SuperFlow Technology that enhances flow rate and reduces the dosage force when injecting. It features an ultra-sharp, multi-bevel, tapered point, and a flat base for improved skin contact and comfort.The NovoFine Plus needles are also designed to resist bending or breaking.
Other Novo Nordisk pen needles include: NovoTwist 32G Tip, NovoFine 32G Tip, and NovoFine Autocover 30G.
For more information visit NovoNordisk-US.com.